[Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
D016255:Anistreplase; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008657:Metabolic Clearance Rate; D008970:Molecular Weight; D009203:Myocardial Infarction / Q000188:drug therapy; D010958:Plasminogen / Q000494:pharmacology / Q000627:therapeutic use*; D010960:Plasminogen Activators / Q000502:physiology / Q000627:therapeutic use*; D013300:Streptokinase / Q000494:pharmacology / Q000627:therapeutic use*; D014568:Urokinase-Type Plasminogen Activator / Q000502:physiology / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D016255:Anistreplase; D005340:Fibrinogen; D010958:Plasminogen; C043149:BRL 33575; D013300:Streptokinase; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator
Les acyl-enzymes et la pro-urokinase: nouveaux agents thrombolytiques prometteurs.